What is the recommended levothyroxine dose for a 31-year-old woman who is 7 weeks pregnant, weighs 103 kg, and has a thyroid‑stimulating hormone level of 4.78 mIU/L?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended Levothyroxine Dose

Start levothyroxine at 103 mcg daily (approximately 1.0 mcg/kg/day based on her 103 kg weight) for this newly diagnosed hypothyroidism in pregnancy with TSH of 4.78 mIU/L.

Rationale

This patient has new-onset hypothyroidism during pregnancy with a TSH of 4.78 mIU/L at 7 weeks gestation. Her TSH is elevated above the first-trimester upper limit of 2.5 mIU/L 1, but remains below 10 mIU/L, which defines her condition as subclinical hypothyroidism requiring treatment.

Dosing Strategy Based on TSH Level

The FDA label provides clear guidance for new-onset hypothyroidism in pregnancy 2:

  • TSH < 10 mIU/L: Start at 1.0 mcg/kg/day
  • TSH ≥ 10 mIU/L: Start at 1.6 mcg/kg/day

Since her TSH is 4.78 mIU/L (below 10), the appropriate starting dose is 1.0 mcg/kg/day × 103 kg = 103 mcg daily.

The Endocrine Society guidelines support this approach, recommending 25-50 mcg/day increments for TSH levels between 5-10 mIU/L when first checked during pregnancy 1. However, the FDA label's weight-based dosing provides more precision for this specific clinical scenario.

Supporting Research Evidence

Recent research validates this dosing strategy:

  • A 2013 study found that women with subclinical hypothyroidism and TSH ≤ 4.2 mIU/L required approximately 1.20 mcg/kg/day, while those with TSH 4.2-10 mIU/L needed 1.42 mcg/kg/day 3
  • With her TSH of 4.78 mIU/L, she falls into the higher subclinical range, making 1.0 mcg/kg/day an appropriate starting point that can be adjusted upward if needed

Critical Timing Considerations

This is urgent. At 7 weeks gestation, she is in the critical window for fetal neurodevelopment. The goal is to achieve TSH ≤ 2.5 mIU/L as rapidly as possible 1, 2:

  • Thyroid hormone requirements increase as early as 5 weeks of gestation 4
  • The first trimester is when fetal brain development is most dependent on maternal thyroid hormone
  • Starting with an adequate dose (rather than titrating up slowly) allows 89% of patients to reach target TSH without additional adjustments 3

Monitoring Plan

Check TSH in 4 weeks and adjust the dose to maintain TSH ≤ 2.5 mIU/L throughout the first trimester 2:

  • Continue monitoring every 4 weeks until TSH is stable within trimester-specific ranges
  • Second and third trimester target: TSH ≤ 3.0 mIU/L 1
  • Expect that she may need dose increases during pregnancy (average 30-50% increase from baseline) 1, 4

Common Pitfalls to Avoid

  1. Don't start too low: Beginning with 25-50 mcg and slowly titrating wastes precious time during critical fetal development. The weight-based approach gets patients to target faster 3

  2. Don't use non-pregnant reference ranges: TSH 4.78 mIU/L would be "normal" by standard lab ranges (0.4-4.0 mIU/L), but is abnormally elevated for first trimester pregnancy where the upper limit is 2.5 mIU/L 1

  3. Don't delay treatment: Even though this is "subclinical" hypothyroidism, treatment is indicated because TSH is above the pregnancy-specific reference range, and delays risk adverse outcomes including miscarriage 5

  4. Ensure proper administration: Take levothyroxine on an empty stomach, 30-60 minutes before breakfast, avoiding calcium, iron, and other interfering medications 2

The practical dose would be 100 mcg daily (the closest available tablet strength to the calculated 103 mcg), which can be fine-tuned based on the 4-week TSH result 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.